Thaer Mahdi Madlool Al-Rammahi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Thaer Mahdi Madlool Al-Rammahi has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Richard A. Henderson
School of Chemistry, Newcastle University, Newcastle upon Tyne, UK
3 shared publications - Ahmed Fadhil Khudhair
Department of Chemistry, College of Science, University of Karbala, Karbala, Iraq
1 shared publication - Ammar Waham Ashor
Human Nutrition Research Centre, Institute of Cellular Medicine, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, NE4 5PL, UK
1 shared publication - Haidar Fadhil Al-Rubaye
National Diabetes Center, Mustansiriyah University
1 shared publication Michael Probert
School of Chemistry, Newcastle University, Newcastle upon Tyne, NE1 7RU, UK
1 shared publicationPaul G. Waddell
School of Chemistry, Newcastle University, Newcastle upon Tyne, NE1 7RU, UK
1 shared publication
Latest Publications
- Open Access
- 1 December 2025
- Published by Universitas Gadjah Mada in Indonesian Journal of Chemistry
- Vol. 25 (6) , 1870
Graphene Oxide Functionalized Based on Dispersive Solid Phase Extraction of Vitamin B12 Spectrophotometric Determination in Pharmaceutical Samples
Sample treatment is crucial for detecting target compounds in complex matrices. Recently, graphene oxide (GO) and its composites have garnered attention as sorbents for sample preparation; however, their application in vitamin B12 (VB12) extraction has not been fully explored. In this study, a dispersive solid-phase extraction (D-SPE) method was developed for the spectrophotometric determination of VB12 in pharmaceutical samples using GO, chitosan (CTS), and a GO/CTS composite as sorbents. The materials were characterized using FTIR, XRD, BET, and FESEM. Extraction conditions were optimized, such as pH, sorbent amount, contact time, eluent type and volume, and desorption temperature. Under these conditions, the developed D-SPE method achieved linear calibration ranges of 0.05–15, 0.1–10, and 0.02–10 µg mL−1, with correlation coefficients of 0.9997, 0.9990, and 0.9998, respectively, after extracting VB12 with GO, CTS, and GO/CTS. The limits of quantification were in the range of 1.00–2.09 µg mL−1, with relative standard deviations of less than 0.11% (n = 3). Recoveries in pharmaceutical samples ranged from 95.1 to 112.8% (GO), 91.8 to 95.5% (CTS), and 87.5 to 103.8% (GO/CTS). These results demonstrate that the GO/CTS composite is an efficient and reliable adsorbent for extracting VB12 in pharmaceutical applications.
- 1 December 2025
- Published by Universitas Gadjah Mada in Indonesian Journal of Chemistry
- Vol. 25 (6) , 1870
Open AccessGraphene Oxide Functionalized Based on Dispersive Solid Phase Extraction of Vitamin B12 Spectrophotometric Determination in Pharmaceutical Samples
Sample treatment is crucial for detecting target compounds in complex matrices. Recently, graphene oxide (GO) and its composites have garnered attention as sorbents for sample preparation; however, their application in vitamin B12 (VB12) extraction has not been fully explored. In this study, a dispersive solid-phase extraction (D-SPE) method was developed for the spectrophotometric determination of VB12 in pharmaceutical samples using GO, chitosan (CTS), and a GO/CTS composite as sorbents. The materials were characterized using FTIR, XRD, BET, and FESEM. Extraction conditions were optimized, such as pH, sorbent amount, contact time, eluent type and volume, and desorption temperature. Under these conditions, the developed D-SPE method achieved linear calibration ranges of 0.05–15, 0.1–10, and 0.02–10 µg mL−1, with correlation coefficients of 0.9997, 0.9990, and 0.9998, respectively, after extracting VB12 with GO, CTS, and GO/CTS. The limits of quantification were in the range of 1.00–2.09 µg mL−1, with relative standard deviations of less than 0.11% (n = 3). Recoveries in pharmaceutical samples ranged from 95.1 to 112.8% (GO), 91.8 to 95.5% (CTS), and 87.5 to 103.8% (GO/CTS). These results demonstrate that the GO/CTS composite is an efficient and reliable adsorbent for extracting VB12 in pharmaceutical applications.
- Open Access
- 1 December 2021
- Published by Enviro Research Publishers in Current Research in Nutrition and Food Science Journal
- Vol. 9 (3) , 945-952
The Association of Higher Composite Biomarker Score of Antioxidant Vitamins with Lower Cardiovascular Diseases Risk: A Cross-Sectional Study
- 1 December 2021
- Published by Enviro Research Publishers in Current Research in Nutrition and Food Science Journal
- Vol. 9 (3) , 945-952
Open AccessThe Association of Higher Composite Biomarker Score of Antioxidant Vitamins with Lower Cardiovascular Diseases Risk: A Cross-Sectional Study
- 23 August 2019
- Published by AIP Publishing in AIP Conference Proceedings
- Vol. 2144 (1) , 020011
Synthesis, protonation and x-ray crystal structures of [Ni(SC6H3Me2-2,6){triphos}]BPh4 and [Ni(SC6H4R-2){triphos}]BPh4 {R = Me, MeO Or Cl; triphos = PhP(Ph2PCH2CH2)2}: Unusual structure when R = Cl
The preparations of [Ni(SC6H3Me-2,6)(triphos)]BPh4 and [Ni(SC6H4R-2)(triphos)]BPh4 (R = Me, MeO or Cl) are described. The complexes have been characterised by 1H and 31P{1H} NMR spectroscopies, UV-visible spectroscopy and X-ray crystallography. Whilst [Ni(SC6H3Me-2,6)(triphos)]BPh4 and [Ni(SC6H4R-2)(triphos)]BPh4 (R = Me, MeO) contain a 4-coordinate square planar Ni, ligated by a thiolate S and three phosphorus atoms of triphos, [Ni(SC6H4Cl-2)(triphos)]BPh4 is a distorted square-based pyramid due to the 2-Cl substituent being weakly bound in the apical position. The protonation of all the complexes have been studied in MeCN in situ using 31P{1H} NMR spectroscopy. The protonation of these complexes with lutH+ (lut = 2,6-dimethylpyridine) indicate simple protonation of the thiolate S. However, protonation by picH+ (pic = 4-methylpyridine) indicate that both protonation and displacement of the thiolate occurs.
- 23 August 2019
- Published by AIP Publishing in AIP Conference Proceedings
- Vol. 2144 (1) , 020011
Synthesis, protonation and x-ray crystal structures of [Ni(SC6H3Me2-2,6){triphos}]BPh4 and [Ni(SC6H4R-2){triphos}]BPh4 {R = Me, MeO Or Cl; triphos = PhP(Ph2PCH2CH2)2}: Unusual structure when R = Cl
The preparations of [Ni(SC6H3Me-2,6)(triphos)]BPh4 and [Ni(SC6H4R-2)(triphos)]BPh4 (R = Me, MeO or Cl) are described. The complexes have been characterised by 1H and 31P{1H} NMR spectroscopies, UV-visible spectroscopy and X-ray crystallography. Whilst [Ni(SC6H3Me-2,6)(triphos)]BPh4 and [Ni(SC6H4R-2)(triphos)]BPh4 (R = Me, MeO) contain a 4-coordinate square planar Ni, ligated by a thiolate S and three phosphorus atoms of triphos, [Ni(SC6H4Cl-2)(triphos)]BPh4 is a distorted square-based pyramid due to the 2-Cl substituent being weakly bound in the apical position. The protonation of all the complexes have been studied in MeCN in situ using 31P{1H} NMR spectroscopy. The protonation of these complexes with lutH+ (lut = 2,6-dimethylpyridine) indicate simple protonation of the thiolate S. However, protonation by picH+ (pic = 4-methylpyridine) indicate that both protonation and displacement of the thiolate occurs.
- 21 April 2016
- Published by Springer Nature in Transition Metal Chemistry
- Vol. 41 (5) , 555-561
X-ray crystal structures of [NHR3]2[Fe4S4X4] (X = PhS, R = Et or n Bu; X = Cl, R = n Bu): implications for sites of protonation in Fe–S clusters
- 21 April 2016
- Published by Springer Nature in Transition Metal Chemistry
- Vol. 41 (5) , 555-561
X-ray crystal structures of [NHR3]2[Fe4S4X4] (X = PhS, R = Et or n Bu; X = Cl, R = n Bu): implications for sites of protonation in Fe–S clusters
- 8 December 2015
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 45 (4) , 1373-1381
Binding small molecules and ions to [Fe 4 S 4 Cl 4 ] 2− modulates rate of protonation of the cluster
Binding various small molecules and ions (Cl − , N 3 − , NCS − , substituted hydrazines, Bu t NC or pyridine) to [Fe 4 S 4 Cl 4 ] 2− facilitates the subsequent protonation of the cluster.
- 8 December 2015
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 45 (4) , 1373-1381
Binding small molecules and ions to [Fe 4 S 4 Cl 4 ] 2− modulates rate of protonation of the cluster
Binding various small molecules and ions (Cl − , N 3 − , NCS − , substituted hydrazines, Bu t NC or pyridine) to [Fe 4 S 4 Cl 4 ] 2− facilitates the subsequent protonation of the cluster.
- 20 November 2015
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 45 (1) , 307-314
Exploring the acid-catalyzed substitution mechanism of [Fe 4 S 4 Cl 4 ] 2−
Kinetic studies focussing on either the protonation or substitution step of the acid catalyzed substitution reactions of [Fe 4 S 4 Cl 4 ] 2− support a mechanism involving concomitant cluster protonation and Fe–(μ 3 -SH) bond cleavage.
- 20 November 2015
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 45 (1) , 307-314
Exploring the acid-catalyzed substitution mechanism of [Fe 4 S 4 Cl 4 ] 2−
Kinetic studies focussing on either the protonation or substitution step of the acid catalyzed substitution reactions of [Fe 4 S 4 Cl 4 ] 2− support a mechanism involving concomitant cluster protonation and Fe–(μ 3 -SH) bond cleavage.